← Back to all trials
Recruiting
NCT07374185
Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis
Conditions: Liver Cirrhosis
Sex: All
Ages: N/A – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 10
Sponsor: Global Stem Cell Center, Baghdad
Location: Capital Private Hospital Alrabee Street Baghdad Iraq
Summary
the study includes patients with liver cirrhosis irrespective of the stage excluding people with active tumor or other major health issue endangering life, the protocol includes the use of autologous bone marrow derived mononuclear cells harvested from the same patient under local anesthesia ,followed by cell concentration and viability testing , then final product is combined with small volume of 2 cc of Wharton gel exosomes 20 billion per to be administered intravenously.
Eligibility Criteria
Inclusion Criteria: any patient with liver cirrhosis , less than 80 years of age -
Exclusion Criteria:
1. active malignancy.
2. severe sepsis.
3. pregnancy. -
Source: ClinicalTrials.gov (NCT07374185). StuddyBuddy aggregates publicly available trial information.
